A Study to Evaluate the Efficacy of Somatropin in the Treatment of Patellar Tendinopathy

Exclusion Criteria

• •Patients who have received corticosteroid injections within 12 months
• •Patients who have full-width disruptions of the patellar tendon
• •Patients who have undergone previous knee surgery or intraarticular injury
• •Patients who have have arthritis (Kellgren and Lawrence grade 2 or higher), open growth plates, diabetes, cardiovascular disease, history of cancer or any major medical illnesses or endocrine disorders
• •Patients with a body mass index greater than 35
• •Women who are pregnant or planning to become pregnant
• •Patients who are current collegiate, professional or elite athletes, or are participating in sports organizations that currently ban the use of somatropin